Products
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Equine Tumor Necrosis Factor (TNF), N-His
Product Overview
BioVenic's Recombinant Equine Tumor Necrosis Factor (TNF), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 19.1 kDa. The purity is>90% (SDS-PAGE).
Specifications
Type Recombinant Protein
Species Equine
Expression System E.coli
Purity >90% (SDS-PAGE)
Predicted Molecular Weight 19.1 kDa
Physical State Lyophilized
Formulation 10 mM Hepes, 500 mM NaCl with 5% trehalose, pH 7.4.
Target Information
Tumor necrosis factor is encoded by the TNF gene in horses. Research has shown that serum TNF activity is correlated with clinical criteria of sepsis in equine neonates.
Protein Equine Tumor Necrosis Factor (TNF)
Protein Synonym tumor necrosis factor; TNF-a; TNF-alpha; TNFA; TNFSF2; TNLG1F; cachectin; tumor necrosis factor (TNF superfamily; member 2); tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; tumor necrosis factor-alpha
Gene ID 100033834
UniProt ID P29553
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in sterile distilled water or other buffer to a concentration of 0.1-1 mg/mL. Aliquote the reconstituted solution to minimise freeze-thaw cycles.